Objective: To evaluate the adequacy of cytology alone for diagnosis of
grade of cervical intraepithelial neoplasia (CIN) and to study perfor
mance of cytology, human papillomavirus (HPV) testing, and colposcopy
in the evaluation of cytologic findings suggesting low-grade squamous
intraepithelial lesions (SIL), or atypical squamous (ASCUS) or atypica
l glandular (AGCUS) cells of undetermined significance. Methods: Stand
ard gynecologic and cytologic evaluation and colposcopic inspection as
an additional screening approach were performed on women with no prio
r hysterectomies screened in a private practice between January 1, 199
3, and August 1, 1995. Among these 7651 women, 367 had ASCUS, AGCUS, o
r SIL cytology or clinically or colposcopically visible cervical lesio
ns. Sensitivity, specificity, and relative risk of CIN in the 367 wome
n were compared by colposcopic, cytologic, histologic and virologic di
agnoses. Results: The sensitivity bf all non-negative Papanicolaou sme
ars for CIN 2-3 and cancer was 92%, combined cytologic categories of h
igh- and low-grade SIL were 59%, and high-grade SIL alone was 22%. Col
poscopy was performed in all 367 patients, and positive findings led t
o biopsies in 48%. Colposcopy bf patients with ASCUS increased detecti
on of CIN 2-3 by 32% and CIN 1 by 48%. Cervical cytology was false neg
ative in 8% of patients with CIN 2-3 and in 14% of those with CIN 1. T
hese cases of CIN were detected by screening colposcopic inspection. H
igh-risk HPV DNA was positive in 41% of women with CIN 2-3, and in 25%
of those with CIN 1. The positive predictive value of ASCUS cytology
increased from 5% to 42% for CIN 2-3 and from 30% to 85% for all grade
s of CIN in patients carrying high-risk HPV DNA. Virologic studies did
not add to an increase in the sensitivity for CIN 2-3 among women in
the low- and high-grade SIL cytology groups. Conclusion: Because of th
e limited sensitivity of the high-grade SIL cytologic category for CIN
2-3, we recommend that all women with ASCUS, AGCUS, low- or high-grad
e SIL cytology be recalled for colposcopy, with biopsy only when indic
ated by colposcopic findings. (Obstet Gynecol 1998;92:601-7. (C) 1998
by The American College of Obstetricians and Gynecologists.).